Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 18.294K |
Day Range | - - - |
52 Wk Range | 0.760 - 9.680 |
Market Cap | $38.861M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 1.69% |
Days to Cover | 5.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Marker Therapeutics (NASDAQ: MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
The latest price target for Marker Therapeutics (NASDAQ: MRKR) was reported by Roth Capital on Thursday, February 17, 2022. The analyst firm set a price target for 1.00 expecting MRKR to fall to within 12 months (a possible -75.06% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $4.01 last updated April 19, 2024 at 8:49 AM EDT.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.